Furthermore, the microbiome-driven modulation of systemic cytokine profiles—such as increased IL-12, IFN-γ, and TNF-α—has been observed in responders to checkpoint blockade, suggesting a role in bridging gut and tumor immune environments [216,217]. This evidence concerns the gene IFNG and neoplasm.